# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts s...
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.
- Reuters
PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ s...
Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $85 t...
Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $104 to $105.
- Reuters
Oppenheimer analyst Steven Lichtman maintains Medtronic (NYSE:MDT) with a Perform and raises the price target from $92 to $94.